DeutschNewstral
Article
The Times of India on 2021-08-11 06:30
DCGI approves study on mixing Covaxin, Covishield
Related news
CDSCO expert panel recommends nod to study on mixing doses of Covaxin, CovishieldThe Hindu- Mixing Covaxin and Covishield is safe and effective: ICMRThe Times of India
- DCGI approves Covaxin for children above 12 yearsThe Times of India
- Study on Covaxin, Covishield mix shows better results, ICMR saysThe Times of India
- Covishield-Covaxin mix offers better shield, says ICMR studyThe Times of India
- Covishield produces more anti-bodies than Covaxin, says studyThe Hindu
- Coronavirus | More antibodies produced after Covishield than Covaxin, says studyThe Hindu
- DCGI approves Phase 2/3 clinical trial of Covaxin in age group of 2-18The Hindu
- Mix and match of Covishield and Covaxin safe, more effective: ICMR studyThe Times of India
- Drug Controller General approves Covishield and Covaxin in India for ‘emergency use’The Hindu
- DCGI nod for Covaxin human trialsThe Hindu
- 'Covishield, Covaxin can protect against Omicron'The Times of India
- Better protection with Covishield-Covaxin combination: ICMRThe Hindu
- Covishield, Covaxin granted conditional market nodThe Times of India
- Covishield, Covaxin made fewer antibodies against B.1.617 variantThe Hindu
- Covishield, Covaxin to get full approval but won’t be retailingThe Times of India
- Live: Corbevax gets nod as booster after Covishield, CovaxinThe Times of India
- Covaxin, Covishield get regular market nod, with some ridersThe Times of India
- Won't recognise your vaccine certificates if you don't clear Covaxin, Covishield: India to EUThe Times of India
- Regular market approval granted for Covishield, Covaxin for use in adult populationThe Hindu